Jump Financial’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Buy
452,502
+92,448
+26% +$613K 0.02% 779
2026
Q1
$2.61M Buy
360,054
+46,545
+15% +$606K 0.03% 561
2025
Q4
$5.33M Buy
+313,509
New +$3.19M 0.07% 356
2025
Q2
Sell
-41,761
Closed -$337K 2235
2025
Q1
$337K Sell
41,761
-81,946
-66% -$896K ﹤0.01% 1245
2024
Q4
$1.53M Buy
+123,707
New +$1.65M 0.03% 602
2024
Q2
Sell
-59,082
Closed -$365K 2340
2024
Q1
$365K Buy
+59,082
New +$296K 0.01% 1346
2023
Q4
Sell
-23,545
Closed -$135K 2312
2023
Q3
$135K Buy
+23,545
New +$107K 0.01% 1628
2023
Q1
Sell
-78,187
Closed -$547K 2115
2022
Q4
$547K Buy
+78,187
New +$360K 0.03% 729

Other funds holding WVE

Jump Financial's WVE Position: Q2 2026 in Review

Jump Financial increased its Wave Life Sciences (WVE) stake by 26% in Q2 2026, buying an estimated $613K and bringing the position to 452,502 shares worth $2.63M. The position accounts for 0.02% of the portfolio, ranked #779.

Jump Financial first reported a position in WVE in Q4 2022 and has held it in 8 quarters since. The position peaked at $5.33M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Jump Financial held 452,502 shares of Wave Life Sciences worth $2.63M as of Q2 2026.
  • Jump Financial bought 92,448 Wave Life Sciences shares in Q2 2026, an estimated $613K.
  • Wave Life Sciences made up 0.02% of Jump Financial's portfolio in Q2 2026, its #779 holding.
  • Jump Financial first reported a position in Wave Life Sciences in Q4 2022 and has held it in 8 quarters since.
  • Jump Financial's Wave Life Sciences position peaked at $5.33M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.